SARS-CoV-2-derived peptides define heterologous and COVID-19-induced T cell recognition

Annika Nelde, Tatjana Bilich, Jonas S. Heitmann, +39

Nature Immunology

Sars-cov-2-derived PeptidesImmunologyAntigen ProcessingMedicineCovid-19

A COVID-19 peptide vaccine for the induction of SARS-CoV-2 T cell immunity

Jonas S. Heitmann, Tatjana Bilich, Claudia Tandler, +24

Nature

T cell and antibody kinetics delineate SARS-CoV-2 peptides mediating long-term immune responses in COVID-19 convalescent individuals

Tatjana Bilich, Annika Nelde, Jonas S. Heitmann, +13

Science Translational Medicine

The antigenic landscape of multiple myeloma: mass spectrometry (re)defines targets for T-cell–based immunotherapy

Simon Walz, Juliane S. Stickel, Daniel J. Kowalewski, +12

Blood

Integrative -omics and HLA-ligandomics analysis to identify novel drug targets for ccRCC immunotherapy

Anna Reustle, Moreno Di Marco, Carolin Meyerhoff, +19

Genome Medicine

Exploring beyond clinical routine SARS-CoV-2 serology using MultiCoV-Ab to evaluate endemic coronavirus cross-reactivity

Matthias Becker, Monika Strengert, Daniel Junker, +33

Nature Communications

Magnetic Bead-Based Immunoassay Allows Rapid, Inexpensive, and Quantitative Detection of Human SARS-CoV-2 Antibodies

Luciano F. Huergo, Khaled A. Selim, Marcelo S. Conzentino, +24

ACS Sensors

The HLA ligandome landscape of chronic myeloid leukemia delineates novel T-cell epitopes for immunotherapy

Tatjana Bilich, Annika Nelde, Leon Bichmann, +22

Blood

Durable spike-specific T cell responses after different COVID-19 vaccination regimens are not further enhanced by booster vaccination

Yacine Maringer, Annika Nelde, Sarah M. Schroeder, +6

Science Immunology

The oncogenic fusion protein DNAJB1-PRKACA can be specifically targeted by peptide-based immunotherapy in fibrolamellar hepatocellular carcinoma

Jens Bauer, Natalie Köhler, Yacine Maringer, +26

Nature Communications